Concepedia
Statistics
Publications
11
Citations
830
H-Index
Active since
1996
Affiliations
Harvard University(Current)
Beth Israel Deaconess Medical Center
Takeda (United States)
Keli Song is an author at Harvard University specializing in oncology, life sciences, and immunology.
Publications per year
1996–2022
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer
Steven Langston, Stephen Grossman, Dylan B. England et al. · Journal of Medicinal Chemistry · 2021 · 208 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +11
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models
Eric S. Lightcap, Pengfei Yu, Stephen Grossman et al. · Science Translational Medicine · 2021 · 140 citations · Full text
Medicine, Immunology, Oncology +13
Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis
Marc Peters‐Golden, Keli Song, Teresa M. Marshall et al. · Biochemical Journal · 1996 · 128 citations · Full text
Life Sciences, Biochemistry, Cell Biology +15
Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase
Shideh Kazerounian, Mark Duquette, Millys A. Reyes et al. · Blood · 2011 · 74 citations · Full text
Life Sciences, Cell Biology, Immunology +13
The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation
Akito Nakamura, Stephen Grossman, Keli Song et al. · Blood · 2022 · 71 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 11